104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants

NCT00664573 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
339
Enrollment
INDUSTRY
Sponsor class

Stopped Analysis of data from 104RA202 failed to meet primary endpoint

Conditions

Interventions

Sponsor

Biogen